Process View
Any process that modulates the frequency, rate, or extent of the chemical reactions and pathways resulting in the breakdown of triglyceride.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of triglyceride catabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CDK2 | cyclin-dependent kinase 2 | 1.000 | Yeast | |
| ALB | albumin | 1.000 | ||
| HP | haptoglobin | 0.998 | ||
| APOA2 | apolipoprotein A-II | 0.996 | ||
| APOC1 | apolipoprotein C-I | 0.982 | ||
| FGA | fibrinogen alpha chain | 0.982 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.970 | ||
| APOE | apolipoprotein E | 0.941 | ||
| CKS1B | CDC28 protein kinase regulatory subunit 1B | 0.715 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.658 | ||
| CCNE1 | cyclin E1 | 0.642 | ||
| UBE2R2 | ubiquitin-conjugating enzyme E2R 2 | 0.596 | ||
| TTR | transthyretin | 0.456 | ||
| TXNDC2 | thioredoxin domain containing 2 (spermatozoa) | 0.364 | ||
| CCNA2 | cyclin A2 | 0.287 | ||
| APOC2 | apolipoprotein C-II | 0.229 | ||
| APOA4 | apolipoprotein A-IV | 0.226 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.221 | ||
| APOA1 | apolipoprotein A-I | 0.181 | Human | |
| HMGB2 | high mobility group box 2 | 0.178 | ||
| CCNB2 | cyclin B2 | 0.171 | ||
| PTPN5 | protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) | 0.155 | ||
| CDKN3 | cyclin-dependent kinase inhibitor 3 | 0.113 | ||
| F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 0.109 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.103 | ||
| AKT2 | v-akt murine thymoma viral oncogene homolog 2 | 0.096 | ||
| FANCC | Fanconi anemia, complementation group C | 0.087 | ||
| SKP1 | S-phase kinase-associated protein 1 | 0.064 | ||
| FAM83C | family with sequence similarity 83, member C | 0.054 | ||
| CLEC4G | C-type lectin domain family 4, member G | 0.039 | ||
| GBF1 | golgi brefeldin A resistant guanine nucleotide exchange factor 1 | 0.038 | ||
| TF | transferrin | 0.035 | ||
| HPX | hemopexin | 0.032 | ||
| F2 | coagulation factor II (thrombin) | 0.029 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.029 | ||
| APOC3 | apolipoprotein C-III | 0.022 | ||
| EEF2K | eukaryotic elongation factor-2 kinase | 0.022 | ||
| KRT1 | keratin 1 | 0.021 | ||
| SNX27 | sorting nexin family member 27 | 0.019 | ||
| TP53BP2 | tumor protein p53 binding protein, 2 | 0.016 | ||
| AMBP | alpha-1-microglobulin/bikunin precursor | 0.016 | ||
| KRT16 | keratin 16 | 0.016 | ||
| AFP | alpha-fetoprotein | 0.015 | ||
| INCENP | inner centromere protein antigens 135/155kDa | 0.015 | ||
| ORC1 | origin recognition complex, subunit 1 | 0.015 | ||
| APOC4 | apolipoprotein C-IV | 0.015 | ||
| CALCOCO1 | calcium binding and coiled-coil domain 1 | 0.014 | ||
| LIPE | lipase, hormone-sensitive | 0.012 | ||
| NUSAP1 | nucleolar and spindle associated protein 1 | 0.012 | ||
| FGL1 | fibrinogen-like 1 | 0.012 | ||
| WDTC1 | WD and tetratricopeptide repeats 1 | 0.012 | ||
| C4BPB | complement component 4 binding protein, beta | 0.012 | ||
| CPB2 | carboxypeptidase B2 (plasma) | 0.012 | ||
| IDUA | iduronidase, alpha-L- | 0.011 | ||
| ABTB1 | ankyrin repeat and BTB (POZ) domain containing 1 | 0.011 | ||
| HPD | 4-hydroxyphenylpyruvate dioxygenase | 0.010 | ||
| CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.010 | ||
| ASGR2 | asialoglycoprotein receptor 2 | 0.010 | ||
| PPDPF | pancreatic progenitor cell differentiation and proliferation factor homolog (zebrafish) | 0.010 | ||
| SPEF2 | sperm flagellar 2 | 0.010 | ||
| CFB | complement factor B | 0.010 | ||
| BAAT | bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) | 0.010 |